Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like Akebia Announces $85M Public Offering March 22, 2018 iCAD Wins FDA Approval for PowerLook Tomo Detection March 26, 2017 Ariad Stays Mum on Layoffs After Takeda's $5.2 Billion Takeover January 26, 2017
